ATI vs BCPC vs EMN Stock Comparison

Ati, Balchem and Eastman Chemical Prices as of Nov 13, 2026 Peers: Industry group
ATI Ati Inc
$183.11 -2.5% 1M +85.8% 1Y
Market cap
$24.29B
P/E
43.7x
Revenue (TTM)
$5.01B
Div. yield
–
Specialty Chemicals Basic Materials
4 wins
BCPC Balchem Corp
$173.14 +1.6% 1M +10.3% 1Y
Market cap
$5.51B
P/E
32.3x
Revenue (TTM)
$1.11B
Div. yield
–
Specialty Chemicals Basic Materials
5 wins
EMN Eastman Chemical Co
$65.05 +3.4% 1M +3.7% 1Y
Market cap
$7.32B
P/E
8.0x
Revenue (TTM)
$9.05B
Div. yield
–
Specialty Chemicals Basic Materials
2 wins

Head to Head

11 decided of 12

Balchem leads on 5 of the 12 questions below (Balchem 5, Ati 4, Eastman Chemical 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionATIBCPCEMNLeader
Larger companyMarket capitalisation $24.29B $5.51B $7.32B ATI
Cheaper on earningsLower P/E, profitable companies only 43.7x 32.3x 8.0x EMN
Cheaper on forward earningsLower price / next fiscal year consensus EPS 37.8x 33.4x 10.2x EMN
Faster revenue growthRevenue growth, trailing twelve months +9.4% +9.4% +0.3% BCPC
More profitableNet margin, trailing twelve months 11.1% 15.4% 10.1% BCPC
Better return on capitalReturn on invested capital 16.5% 12.1% 7.3% ATI
Less leveragedLower net debt / EBITDA 1.4x 0.3x 3.2x BCPC
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +85.8% +10.3% +3.7% ATI
Better 5-year returnAnnualised price return, 5 years +60.5%/yr +0.9%/yr -10.9%/yr ATI
Less volatileAnnualised volatility, 1 year 43.5% 21.6% 31.6% BCPC
Higher overall scoreMean of the five percentile scores vs peers 60/100 69/100 59/100 BCPC

Percentile Scorecard

ATIBCPCEMN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisATIBCPCEMN
Valuation 18 #79 of 96 34 #64 of 96 85 #15 of 96
Growth 80 #19 of 92 84 #16 of 92 22 #72 of 92
Profitability 88 #12 of 89 89 #11 of 89 64 #33 of 89
Financial Health 55 #44 of 96 88 #12 of 96 32 #66 of 96
Shareholder Returns 62 #31 of 79 51 #39 of 79 94 #6 of 79
Overall 60 69 59
  • ATI ranked among 99 companies in Chemicals
  • BCPC ranked among 99 companies in Chemicals
  • EMN ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodATIBCPCEMNSPY
1 month -2.5%+1.6%+3.4% -2.0%
3 months -19.9%-3.0%-12.2% -2.8%
6 months +18.7%+8.9%-9.1% +2.0%
Year to date +59.6%+12.9%+1.9% +10.6%
1 year +85.8%+10.3%+3.7% +12.2%
3 years +303.6%+37.4%-18.5% +68.1%
3 years, per year +59.3%+11.2%-6.6% +18.9%
5 years +963.4%+4.8%-43.9% +61.4%
5 years, per year +60.5%+0.9%-10.9% +10.1%
10 years +977.8%+122.2%-13.5% +248.5%
10 years, per year +26.8%+8.3%-1.4% +13.3%

Risk

MeasureATIBCPCEMNSPY
Volatility, 1Y 43.5%21.6%31.6% 13.6%
Downside volatility, 1Y 42.8%19.9%29.8% 13.9%
Beta vs S&P 500, 1Y 1.660.180.87 1.00
Return / volatility, 1Y 1.970.480.12 0.90
Max drawdown, 5Y -38.0%-34.1%-55.9% -25.4%
From 52-week high -21.0%-5.5%-20.0% -3.2%
52-week high $231.79$183.26$81.36 $779.14
52-week low $94.80$147.36$56.37 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleATIBCPCEMN
P/E now vs peer median 44.9xmedian 23.4x 32.1xmedian 23.4x 8.1xmedian 23.4x
P/S now vs peer median 5.0xmedian 1.3x 5.0xmedian 1.3x 0.8xmedian 1.3x
EV/EBITDA now vs peer median 26.2xmedian 12.7x 20.1xmedian 12.7x 8.5xmedian 12.7x
P/FCF now vs peer median 59.1xmedian 17.0x 31.0xmedian 17.0x 15.9xmedian 17.0x
P/B now vs peer median 11.7xmedian 1.5x 4.2xmedian 1.5x 1.2xmedian 1.5x
PEG now vs peer median 3.38median 1.72 1.71median 1.72 -13.19median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsATIBCPCEMN
Revenue $5.01B $1.11B $9.05B
Gross profit $1.23B $404.38M $1.86B
Operating income $826.30M $229.57M $868.00M
Net income $568.60M $170.85M $627.00M
Free cash flow $421.10M $178.00M $469.00M
R&D – $20.81M $246.00M
EPS (diluted) $4.01 $5.33 $7.93
Cash & equivalents $442.30M $66.26M $768.00M
Total debt $1.86B $145.94M $5.22B
Shares (diluted) 138.40M 32.03M 115.30M
Enterprise value $22.25B $5.24B $4.63B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricATIBCPCEMN
P/E 44.9x 32.1x 8.1x
P/FCF 59.1x 31.0x 15.9x
P/Operating cash flow 34.1x 24.6x 8.5x
P/S 5.0x 5.0x 0.8x
P/B 11.7x 4.2x 1.2x
P/Tangible book 11.7x 4.6x 1.4x
EV/EBITDA 26.2x 20.1x 8.5x
EV/EBIT 31.8x 24.3x 13.7x
EV/Revenue 5.2x 5.0x 1.3x
EV/FCF 62.4x 31.4x 25.4x
EV/Operating cash flow 36.0x 25.0x 13.5x
PEG (3Y EPS CAGR) 3.38 1.71 -13.19

Growth

14 metrics
MetricATIBCPCEMN
Revenue growth (1Y) 9.4% 9.4% 0.3%
Revenue CAGR (3Y) 6.8% 6.2% -1.2%
Gross profit growth (1Y) 24.9% 11.4% -9.7%
Gross profit CAGR (3Y) 16.1% 11.0% -1.9%
Operating income growth (1Y) 21.7% 12.3% -18.2%
Operating income CAGR (3Y) 21.0% 14.2% -1.2%
Net income growth (1Y) 23.6% 14.5% -13.3%
Net income CAGR (3Y) 9.9% 18.3% 2.2%
EPS growth (1Y) 26.8% 16.5% -17.2%
EPS CAGR (3Y) 13.3% 18.8% -0.6%
Operating cash flow growth (1Y) 7.5% 11.0% -12.8%
Operating cash flow CAGR (3Y) – 12.3% -13.9%
Free cash flow growth (1Y) -5.2% 10.1% 18.7%
Free cash flow CAGR (3Y) – 14.8% -3.8%

Profitability

14 metrics
MetricATIBCPCEMN
Gross margin 24.5% 36.5% 20.6%
EBITDA margin 20.0% 25.1% 15.4%
Operating margin 16.5% 20.7% 9.6%
Pretax margin 13.9% 19.9% 7.2%
Net margin 11.1% 15.4% 10.1%
FCF margin 8.4% 16.1% 5.2%
Operating cash flow margin 14.6% 20.2% 9.7%
Return on equity 27.5% 13.0% 10.0%
Return on assets 10.1% 10.1% 4.1%
Return on invested capital 16.5% 12.1% 7.3%
Return on capital employed 18.1% 15.0% 6.8%
Asset turnover 0.9x 0.7x 0.6x
Cash conversion (OCF / net income) 1.3x 1.3x 1.4x
Stock comp / revenue 0.6% 1.8% –

Financial Health

11 metrics
MetricATIBCPCEMN
Debt / assets 33.4% 8.6% 33.7%
Debt / equity 0.9x 0.1x 0.8x
Net debt / EBITDA 1.4x 0.3x 3.2x
Debt / FCF 4.4x 0.8x 11.1x
Liabilities / assets 61.7% 22.1% 59.0%
Equity / assets 38.3% 77.9% 41.0%
Interest coverage 3.4x – –
Current ratio 2.8x 2.5x 1.6x
Quick ratio 1.2x 1.3x 0.8x
Cash ratio 0.4x 0.4x 0.3x
Altman Z-score 6.39 11.07 2.32

Shareholder Returns

7 metrics
MetricATIBCPCEMN
Dividend yield – 0.6% 5.2%
Net buyback yield 0.8% 2.0% –
Shareholder yield 0.8% 2.6% 5.2%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusATIBCPCEMN
Forward P/E 37.8xFY2026 33.4xFY2026 10.2xFY2026
EPS, next fiscal year $4.85FY2026 $5.19FY2026 $6.39FY2026
EPS growth, next FY +49.7%FY2026 +9.3%FY2026 +17.9%FY2026
EPS growth, the year after +25.8% +7.3% -4.2%
Revenue, next fiscal year $5.34BFY2026 $1.07BFY2026 $9.46BFY2026
Revenue growth, next FY +16.4%FY2026 +2.6%FY2026 +8.2%FY2026
Revenue growth, the year after +13.9% +9.7% -3.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersATIBCPCEMN
Held by institutions 93.5% 90.5% 94.1%
Institutions holding 788 417 651
Change in shares held, QoQ +0.9% +1.5% -0.1%
Institutions buying 481 193 327
Institutions selling 217 162 196
Buyers to sellers 2.22 1.19 1.67

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ATIBCPCEMN
ATI 1.00 0.08 0.22
BCPC 0.08 1.00 0.32
EMN 0.22 0.32 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ATI, BCPC and EMN?

Ati (ATI) is the largest by market capitalisation: Ati (ATI) $24.29B, Balchem (BCPC) $5.51B, Eastman Chemical (EMN) $7.32B.

Which stock is cheaper, ATI, BCPC and EMN?

Eastman Chemical (EMN) trades on the lowest price-to-earnings ratio (Ati (ATI) 43.7x, Balchem (BCPC) 32.3x, Eastman Chemical (EMN) 8.0x). On next year's consensus earnings, Eastman Chemical (EMN) is cheapest (Ati (ATI) 37.8x, Balchem (BCPC) 33.4x, Eastman Chemical (EMN) 10.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Balchem (BCPC) grew revenue fastest over the trailing twelve months: Ati (ATI) +9.4%, Balchem (BCPC) +9.4%, Eastman Chemical (EMN) +0.3%.

Which company is more profitable?

Balchem (BCPC) has the highest net margin (Ati (ATI) 11.1%, Balchem (BCPC) 15.4%, Eastman Chemical (EMN) 10.1%). On return on invested capital, Ati (ATI) leads (Ati (ATI) 16.5%, Balchem (BCPC) 12.1%, Eastman Chemical (EMN) 7.3%).

Which stock has performed better?

Over the past year Ati (ATI) returned the most: Ati (ATI) +85.8%, Balchem (BCPC) +10.3%, Eastman Chemical (EMN) +3.7%. Over five years, Ati (ATI) compounded fastest (Ati (ATI) +60.5%/yr, Balchem (BCPC) +0.9%/yr, Eastman Chemical (EMN) -10.9%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Balchem (BCPC) has been the steadiest (Ati (ATI) 43.5%, Balchem (BCPC) 21.6%, Eastman Chemical (EMN) 31.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ATI, BCPC and EMN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Balchem (BCPC) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.